Code Biotherapeutics
Developer of gene therapies for rare diseases. The therapies are developed for the treatment of Duchenne muscular dystrophy and type 1 diabetes. The company has a non-viral gene delivery platform 3DNA that delivers genes of all sizes, improves cellular targeting, and reduces immunogenicity. Founded in 2020, headquartered in Hatfield, United States. The company has raised $85.0M in funding at the series a stage. The…
Funding snapshot
About
Developer of gene therapies for rare diseases. The therapies are developed for the treatment of Duchenne muscular dystrophy and type 1 diabetes. The company has a non-viral gene delivery platform 3DNA that delivers genes of all sizes, improves cellular targeting, and reduces immunogenicity. Founded in 2020, headquartered in Hatfield, United States. The company has raised $85.0M in funding at the series a stage. The team comprises 22 (Jun 30, 2026) employees. The company operates in the Genomics sector with additional focus on Gene Therapy and Rare Diseases. Its business model centers on Muscle Disorders. Founded in 2020, headquartered in Hatfield, United States. The company has raised $85.0M at the Series A stage. Backed by investors including 4Bio Capital, UPMC, Takeda, New Enterprise Associates, T1D Fund and others.
Business model
Orthopedics > Drugs > Muscle Disorders,
Rare Diseases > Drugs > Musculoskeletal,
Genomics > Applied Genomics > Clinical Genomics > Therapeutics
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like Code Biotherapeutics?
Analyze your pitch deck before your next raise.
Analyze My Deck →